Top Tweets for #AASLD2017

gTt-VIH @gTtVIH

over 8 years ago

#AASLD2017 Resultados prometedores de un nuevo fármaco frente a la #hepatitisB https://t.co/i4P24eXIM3

gTtVIH's tweet photo. #AASLD2017 Resultados prometedores de un nuevo fármaco frente a la #hepatitisB
https://t.co/i4P24eXIM3 https://t.co/0EY1yqpvGt

0

7

7

0

0

HepCure @hepcure

over 8 years ago

In case you missed it, Dr. Paul Kwo of @StanfordMed presented on updates from #AASLD2017! #LiverMtg17 @AASLDtweets Watch it here ... https://t.co/Rx1f5zlIhH

0

2

0

0

0

HepCure @hepcure

over 8 years ago

LIVE! Dr. Paul Kwo of @StanfordMed is presenting updates from #AASLD2017! Join us here #LiverMtg17 @AASLDtweets ... https://t.co/hHXQjANlkS

0

2

0

0

0

HepCure @hepcure

over 8 years ago

Tomorrow (11/21) @ 4:30 PM EST, Dr. Paul Kwo of @StanfordMed will be presenting updates from #AASLD2017! Tune in here ... https://t.co/hHXQjANlkS #LiverMtg17 @AASLDtweets

0

3

1

0

0

gTt-VIH @gTtVIH

over 8 years ago

#AASLD2017 Demanda contra la patente de Gilead sobre sofosbuvir en EE UU https://t.co/AAT6D3WvY9 @infohep

0

1

1

0

0

Paris Charilaou, MD FACP @Dr_PCharilaou

almost 9 years ago · Washington

Promising results of #TIPS in #HRS after exact-matching from a #nationwide cohort - #AASLD2017

Dr_PCharilaou's tweet photo. Promising results of #TIPS in #HRS after exact-matching from a #nationwide cohort - #AASLD2017 https://t.co/Sr9ASHLObk

Dr_PCharilaou's tweet photo. Promising results of #TIPS in #HRS after exact-matching from a #nationwide cohort - #AASLD2017 https://t.co/Sr9ASHLObk

Dr_PCharilaou's tweet photo. Promising results of #TIPS in #HRS after exact-matching from a #nationwide cohort - #AASLD2017 https://t.co/Sr9ASHLObk

0

3

0

0

0

Ligand @Ligand_LGND

almost 9 years ago

$VKTX presents results from in vivo study of VK2809 in NASH at #AASLD2017 https://t.co/082qrNPxfK

0

2

1

0

0

MGH ITA @mgh_ita

almost 9 years ago

@JagChhatwal "Should we transplant HCV+ livers into HCV- patients on the waiting list?" at #AASLD2017 #AASLDtweets #LiverMtg17

mgh_ita's tweet photo. @JagChhatwal "Should we transplant HCV+ livers into HCV- patients on the waiting list?" at #AASLD2017 #AASLDtweets #LiverMtg17 https://t.co/80kjjo8uuk

0

1

0

0

0

Project ECHO @ProjectECHO

almost 9 years ago

.@Surgeon_General @JeromeAdamsMD , thanks for the #ProjectECHO shout out yesterday at the #AASLD2017. We appreciate your support!

0

3

1

0

0

Vivian Ortiz @VivianOrtizMD

almost 9 years ago

An honor to be in the presence of Dr. Lok and Dr. Sokol. @AASLDPresident #AASLD2017 #LiverMtg17 #emergingliverscholars

VivianOrtizMD's tweet photo. An honor to be in the presence of Dr. Lok and Dr. Sokol. @AASLDPresident #AASLD2017 #LiverMtg17 #emergingliverscholars https://t.co/nhCD3AaaFF

0

11

4

0

0

almost 9 years ago

We must treat #pwid for #HCV, low reinfection "We should reach, treat, offer #harmeduction across treaters globally" #AASLD2017 #LiverMtg17

NVHR1's tweet photo. We must treat #pwid for #HCV, low reinfection "We should reach, treat, offer #harmeduction across treaters globally" #AASLD2017 #LiverMtg17 https://t.co/1XEc8z3MFF

0

2

1

0

0

almost 9 years ago

#hepatitis debrief: We need to link all patients with #HCV to care @VeteransHealth leads the way in linkage #AASLD2017 #LiverMtg17

0

3

1

0

0

almost 9 years ago

Hep Debrief: Dr. Kwo highlights effectiveness of #HCV treatment in #PWID & need to do more to reach out to community #AASLD2017 #LiverMtg17

0

1

0

0

0

Vivian Ortiz @VivianOrtizMD

almost 9 years ago

#inspired #AASLD2017 #LiverMtg17 https://t.co/p2Du06h90I

Yale Digestive Diseases @YaleDigestive

almost 9 years ago

Last night Yale Digestive Diseases Alumni Reception AASLD @AASLDtweets @MarioStrazzabos @ggarciatsao @VilarinhoSilvia #LiverMtg17

YaleDigestive's tweet photo. Last night Yale Digestive Diseases Alumni Reception AASLD @AASLDtweets @MarioStrazzabos @ggarciatsao @VilarinhoSilvia #LiverMtg17 https://t.co/dCMBmypUlz

0

4

3

0

0

0

1

0

0

0

Vivian Ortiz @VivianOrtizMD

almost 9 years ago

I'm oficially on tweeter thanks to @HenryEChang. #AASLD2017 #LiverMtg17 https://t.co/HBUIjeKzys

almost 9 years ago

Nice chat w/ @VivianOrtizMD, @AASLDFoundation Emerging Liver Scholar on mentorship & role of social media in career development #LiverMtg17

HenryEChang's tweet photo. Nice chat w/ @VivianOrtizMD, @AASLDFoundation Emerging Liver Scholar on mentorship & role of social media in career development #LiverMtg17 https://t.co/o2wnfk2OUw

0

10

8

0

0

0

2

0

0

0

Joshua Samsoondar @jsamsoondar

almost 9 years ago · Windsor

Nice NASH data from $GILD Nimbus w ACC inhib Strong trends, maybe underpowered for ALT, MRE? #AASLD2017

jsamsoondar's tweet photo. Nice NASH data from $GILD Nimbus w ACC inhib
Strong trends, maybe underpowered for ALT, MRE? #AASLD2017 https://t.co/I3fzr1LIUN

0

6

1

0

0

Vivian Ortiz @VivianOrtizMD

almost 9 years ago

Thank you Dr. Joseph Lim @YaleDigestive and @AASLDFoundation for the opportunity of being here.#AASLD2017 #LiverMtg17 #emergingliverscholars

VivianOrtizMD's tweet photo. Thank you Dr. Joseph Lim @YaleDigestive and @AASLDFoundation for the opportunity of being here.#AASLD2017 #LiverMtg17 #emergingliverscholars https://t.co/E6thmTanco

0

5

4

0

0

MSDsalute @msdsalute

almost 9 years ago

Pazienti con #HCV che si iniettano droghe: una popolazione particolarmente fragile di cui si è parlato ad #AASLD2017

msdsalute's tweet photo. Pazienti con #HCV che si iniettano droghe: una popolazione particolarmente fragile di cui si è parlato ad #AASLD2017 https://t.co/veTwx3cUgN

0

2

0

0

0

gTt-VIH @gTtVIH

almost 9 years ago

#AASLD2017 La curación de la #hepatitisC mejora la calidad de vida de los pacientes https://t.co/1cfNUnGfyH

gTtVIH's tweet photo. #AASLD2017 La curación de la #hepatitisC mejora la calidad de vida de los pacientes
https://t.co/1cfNUnGfyH https://t.co/rgmYbjK3ka

0

1

2

0

0

MSDsalute @msdsalute

almost 9 years ago

In crescita la prevalenza dell’ #HCV in pazienti con #HIV. Si discute del problema #coinfezione ad #AASLD2017

msdsalute's tweet photo. In crescita la prevalenza dell’ #HCV in pazienti con #HIV. Si discute del problema #coinfezione ad #AASLD2017 https://t.co/0BJUnUxfLr

0

3

1

0

0

Last Seen Hashtags on Sotwe

Trends for you

Most Popular Users